• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday

    10/14/22 4:53:25 AM ET
    $ACI
    $ACMR
    $ADMP
    $AFRM
    Food Chains
    Consumer Staples
    Industrial Machinery/Components
    Technology
    Get the next $ACI alert in real time by email

    Gainers

    • Nutex Health Inc. (NASDAQ:NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
    • FedNat Holding Company (NASDAQ:FNHC) shares surged 56.5% to close at $0.3513 on Thursday after dipping 34% on Wednesday.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) gained 42.7% to close at $0.11. Digital Brands Group finalized new agreement for $20 million revenue sundry acquisition scheduled to close in November.
    • Laser Photonics Corporation (NASDAQ:LASE) shares jumped 41.4% to close at $4.13 after the company announced the Coca-Cola Company recently completed the implementation of its first CleanTech Handheld Laser Blasting system in its manufacturing facilities.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) gained 35.8% to close at $1.82.
    • Ambow Education Holding Ltd. (NYSE:AMBO) gained 28.5% to settle at $0.3212. Ambow Education Holding recently posted a Q2 loss of $0.23 per share.
    • Service Properties Trust (NASDAQ:SVC) gained 27.3% to close at $7.04. Service Properties Trust recently entered into agreement to sell 16 hotels for $136.3 million.
    • Oblong, Inc. (NASDAQ:OBLG) jumped 26.5% to close at $0.2299.
    • Revlon, Inc. (NYSE:REV)climbed 21.8% to close at $4.81.
    • United Maritime Corporation (NASDAQ:USEA) gained 21.7% to close at $2.19. United announced sale of two Aframax petroleum tankers and delivery of the previously announced LR2 tankers for $62.5 million.
    • VectivBio Holding AG (NASDAQ:VECT) rose 21.5% to close at $7.90 after the company announced interim data from its STARS Nutrition Phase 2 study of apraglutide. The company also priced a 16.7 million share offering at $7.50 per share.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) climbed 20.6% to close at $0.1326 after dipping 20% on Wednesday.
    • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) gained 19.9% to close at $0.2026. AnPac Bio recently announced board and management changes.
    • Tenon Medical, Inc. (NASDAQ:TNON) rose 19.1% to close at $1.50.
    • SOBR Safe, Inc. (NASDAQ:SOBR) climbed 19.1% to close at $3.05.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) jumped 17.8% to close at $3.77.
    • ACM Research, Inc. (NASDAQ:ACMR) rose 17% to close at $9.48. ACM Research’s subsidiary ACM Research (Shanghai), Inc posted preliminary revenue for the quarter that ended September 30, 2022, and backlog figures for ACM Shanghai as of September 30, 2022.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) gained 16.7% to settle at $0.44.
    • Quad/Graphics, Inc. (NYSE:QUAD) rose 16.7% to close at $2.58.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) rose 16.2% to close at $30.92.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 14.7% to close at $18.30 following Wednesday reports suggesting Google has approved the Truth Social app on the Google Play Store. Digital World is the SPAC merger partner of Truth Social owner Trump Media & Technology.
    • InMode Ltd. (NASDAQ:INMD) rose 14.3% to settle at $34.73 after the company issued Q3 sales guidance above estimates and raised FY22 sales guidance above estimates.
    • Virgin Orbit Holdings, Inc (NASDAQ:VORB) jumped 14% to close at $2.94.
    • Kubient, Inc. (NASDAQ:KBNT) gained 13.5% to settle at $1.01.
    • uCloudlink Group Inc. (NASDAQ:UCL) jumped 12.9% to close at $0.5643.
    • Cepton, Inc. (NASDAQ:CPTN) gained 12.9% to close at $2.62.
    • Smart for Life, Inc. (NASDAQ:SMFL) climbed 12.6% to close at $0.3718.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 12.1% to close at $0.7501.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares climbed 11.5% to close at $46.21. Axsome recently reported Sunosi met the primary endpoint in the SHARP study and significantly improved cognitive function in cognitively impaired patients with excessive daytime sleepiness associated with OSA.
    • NatWest Group plc (NYSE:NWG) rose 10.8% to close at $5.22.
    • Duck Creek Technologies, Inc. (NASDAQ:DCT) shares rose 10.8% to close at $11.95 after the company reported better-than-expected earnings results for its fourth quarter.
    • Albertsons Companies, Inc. (NYSE:ACI) rose 10.5% to close at $28.63. Kroger is said to be in talks to combine with rival Albertsons, Bloomberg said.
    • Domino's Pizza, Inc. (NYSE:DPZ) shares climbed 10.4% to close at $333.26 after the company reported slightly better-than-expected Q3 sales and US same store sales growth of 2%.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) climbed 9.6% to close at $15.26.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) gained 8.3% to close at $8.24. Shares of several banks and financial services companies traded higher as stocks rebound following weakness earlier in the session. September CPI data came in better-than-expected, which could negatively impact lending as it dims the outlook for a Fed policy pivot.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) rose 6.8% to close at $0.2990.
    • NeoVolta Inc. (NASDAQ:NEOV) gained 6.3% to close at $4.73.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rose 5.4% to close at $33.65 after the company posted upbeat Q4 results.
    • Delta Air Lines, Inc (NYSE:DAL) gained 4% to close at $30.38 following Q3 earnings. The company guided Q4 revenue up 5-9% from 2019 levels and said it is on track to achieve its 2024 financial targets of over $7 in EPS and $4 billion of free cash flow.


    Losers

    • Relmada Therapeutics, Inc. (NASDAQ:RLMD) shares dropped 79.6% to close at $6.47 on Thursday after the company announced its RELIANCE III study did not achieve its primary endpoint.
    • Otonomy, Inc. (NASDAQ:OTIC) declined 53.5% to close at $0.1210 after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline.
    • mCloud Technologies Corp. (NASDAQ:MCLD) dipped 35.9% to close at $1.4295 after jumping over 39% on Wednesday.
    • 9F Inc. (NASDAQ:JFU) dipped 33.9% to close at $0.2305. Shares of several Chinese companies traded lower as investors assess greater-than-expected US September CPI data, China's zero-Covid policy and the recently-announced US high-end chip export restrictions to China.
    • Happiness Development Group Limited (NASDAQ:HAPP) dropped 23.6% to close at $2.94.
    • FLJ Group Limited (NASDAQ:FLJ) fell 22.1% to close at $2.22.
    • Pintec Technology Holdings Limited (NASDAQ:PT) dipped 21.6% to close at $0.71 after jumping 216% on Wednesday.
    • iPower Inc. (NASDAQ:IPW) fell 19.8% to close at $0.5278.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares dipped 19% to close at $0.14. Adamis Pharmaceuticals recently initiated a process to explore a range of strategic and financing alternatives.
    • Quanergy Systems, Inc. (NYSE:QNGY) fell 16.1% to close at $1.83. Quanergy Systems recently announced a restructuring plan including an 11% staff reduction.
    • AMTD Digital Inc. (NYSE:HKD) fell 15.5% to close at $32.79 after declining over 5% on Wednesday.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) dropped 14.6% to close at $0.7522.
    • Mondee Holdings, Inc. (NASDAQ:MOND) fell 14.3% to close at $7.66.
    • Angi Inc. (NASDAQ:ANGI) fell 13.9% to close at $2.30.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) dropped 13.7% to close at $0.41.
    • Angel Oak Mortgage, Inc. (NYSE:AOMR) dropped 13.4% to close at $10.08. Angel Oak Mortgage recently named Sreeni Prabhu as Chief Executive Officer, President.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) fell 13.3% to close at $8.69. Dragonfly Energy Corp. recently completed business combination with Chardan NexTech Acquisition 2 Corp.
    • Ra Medical Systems, Inc. (NASDAQ:RMED) dropped 12.8% to close at $4.91.
    • LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) dropped 12.6% to close at $9.00.
    • Locafy Limited (NASDAQ:LCFY) dropped 11.5% to close at $0.39.
    • Code Chain New Continent Limited (NASDAQ:CCNC) dropped 10.6% to close at $0.2048.
    • Etsy, Inc. (NASDAQ:ETSY) dropped 9.3% to close at $96.32. Goldman Sachs recently initiated coverage on Etsy with a Buy rating and announced a price target of $130.
    • SG Blocks, Inc. (NASDAQ:SGBX) fell 8.9% to close at $1.63. Shares of several companies in the industrials sector traded lower amid overall market weakness following greater-than-expected September CPI data, which is a potential sign that the Fed will continue to be aggressive in its fight against runaway inflation.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) fell 8.9% to close at $2.55. T2 Biosystems shares dropped 30% on Wednesday after the company cut FY22 sales guidance to below analyst estimates and announced a 1-for-50 reverse stock split.
    • ContextLogic Inc. (NASDAQ:WISH) dropped 8.2% to close at $0.7261.
    • Argo Blockchain plc (NASDAQ:ARBK) shares fell 7.9% to close at $1.86. Argo Blockchain shares fell around 8% on Wednesday after the company announced an operational update for September.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) dipped 5.3% to close at $18.76. Truist Securities maintained Affirm Holdings with a Buy and lowered the price target from $45 to $30.
    • Sea Limited (NYSE:SE) dropped 5.1% to close at $54.45.
    Get the next $ACI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACI
    $ACMR
    $ADMP
    $AFRM

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    Affirm Holdings Inc.
    $AFRM
    1/27/2026$100.00Hold → Buy
    Needham
    Relmada Therapeutics Inc.
    $RLMD
    1/23/2026$8.00Outperform
    Leerink Partners
    Domino's Pizza Inc
    $DPZ
    1/20/2026$455.00Overweight → Equal-Weight
    Morgan Stanley
    Albertsons Companies Inc.
    $ACI
    1/15/2026$14.00Equal-Weight → Underweight
    Morgan Stanley
    Albertsons Companies Inc.
    $ACI
    1/8/2026Hold
    Deutsche Bank
    Axsome Therapeutics Inc.
    $AXSM
    1/8/2026$204.00Overweight → Equal-Weight
    Morgan Stanley
    NatWest Group plc
    $NWG
    1/7/2026Overweight → Equal Weight
    Barclays
    More analyst ratings

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Traversa Sergio bought $113,300 worth of shares (27,500 units at $4.12), increasing direct ownership by 2% to 1,300,000 units (SEC Form 4)

    4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)

    12/16/25 9:30:49 AM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Shenouda Maged bought $48,060 worth of shares (11,665 units at $4.12), increasing direct ownership by 1% to 800,000 units (SEC Form 4)

    4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)

    12/16/25 9:30:24 AM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Bates Jon Christian bought $102,532 worth of shares (750 units at $136.71), increasing direct ownership by 15% to 5,638 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    11/28/25 2:11:24 PM ET
    $NUTX
    Real Estate

    $ACI
    $ACMR
    $ADMP
    $AFRM
    SEC Filings

    View All

    SEC Form 10-K filed by Ambow Education Holding Ltd.

    10-K - Ambow Education Holding Ltd. (0001494558) (Filer)

    2/13/26 5:21:38 PM ET
    $AMBO
    Other Consumer Services
    Real Estate

    Delta Air Lines Inc. filed SEC Form 8-K: Leadership Update

    8-K - DELTA AIR LINES, INC. (0000027904) (Filer)

    2/13/26 5:00:40 PM ET
    $DAL
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 10-Q filed by NeoVolta Inc.

    10-Q - NeoVolta Inc. (0001748137) (Filer)

    2/13/26 4:31:09 PM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DBGI Announces Purchase of Existing Convertible Notes and Note Conversion Extension by Holders

    Austin, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. ("DBG" or the "Company") (Ticker: (NASDAQ: DBGI)), a publicly traded company specializing in eCommerce and Fashion, today announced that existing holders of all of the Company's Series D Preferred Stock (the "Series D Shares") have advised the Company that these holders have entered into various private agreements regarding their respective ownership of, and rights with respect to, the Series D Shares (the "Shareholder Agreements"). Each Series D Share is convertible, at the discretion of the holder thereof, into shares of the Company's common stock (the "Common Stock") at a conversion price equal to, as of the dat

    2/13/26 11:10:00 PM ET
    $DBGI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Ambow Files Annual Report on Form 10-K for Fiscal Year 2025

    CUPERTINO, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. ("Ambow" or the "Company") (NYSE:AMBO), a global innovator of AI-powered phygital (physical + digital) solutions for education, conferencing and events, today announced that it has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (the "SEC"). The Annual Report on Form 10-K can be accessed on the Company's investor relations website at https://www.ambow.com and the SEC's website at https://www.sec.gov. Shareholders and ADS holders may request a hard copy of the Annual Report containing its audited consolidated financial statements, f

    2/13/26 4:48:00 PM ET
    $AMBO
    Other Consumer Services
    Real Estate

    Quad Announces 33% Increase in Quarterly Dividend

    SUSSEX, Wis., Feb. 13, 2026 /PRNewswire/ -- Quad/Graphics, Inc. (NYSE:QUAD) ("Quad" or the "Company"), a marketing experience company that solves complex marketing challenges for its clients, announced today that its Board of Directors approved a 33% increase in the quarterly dividend of the Company's common stock from $0.075 per share, or $0.30 per share on an annualized basis, to $0.10 per share, or $0.40 per share on an annualized basis. The Company also announced today that the Board of Directors declared a quarterly dividend on the Company's common stock at the increased

    2/13/26 8:30:00 AM ET
    $QUAD
    Publishing
    Consumer Discretionary

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Affirm upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Affirm from Equal-Weight to Overweight and set a new price target of $76.00

    2/3/26 6:49:01 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm upgraded by Needham with a new price target

    Needham upgraded Affirm from Hold to Buy and set a new price target of $100.00

    1/27/26 8:33:32 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Leerink Partners resumed coverage on Relmada Therapeutics with a new price target

    Leerink Partners resumed coverage of Relmada Therapeutics with a rating of Outperform and set a new price target of $8.00

    1/23/26 8:21:07 AM ET
    $RLMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACI
    $ACMR
    $ADMP
    $AFRM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    FDA Approval for AUVELITY issued to AXSOME THERAPEUTICS, INC.

    Submission status for AXSOME THERAPEUTICS, INC.'s drug AUVELITY (ORIG-1) with active ingredient DEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDE has changed to 'Approval' on 08/18/2022. Application Category: NDA, Application Number: 215430, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    8/19/22 12:36:14 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Digital & Tech Officer Duggirala Amala was granted 14,080 shares, increasing direct ownership by 85% to 30,550 units (SEC Form 4)

    4 - DELTA AIR LINES, INC. (0000027904) (Issuer)

    2/13/26 4:45:43 PM ET
    $DAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Chief Operating Officer Linford Michael exercised 20,000 shares at a strike of $49.00, increasing direct ownership by 25% to 100,269 units (SEC Form 4)

    4 - Affirm Holdings, Inc. (0001820953) (Issuer)

    2/11/26 4:00:58 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by EVP, M&A and Corporate Affairs Moriarty Thomas M

    4 - Albertsons Companies, Inc. (0001646972) (Issuer)

    2/10/26 7:36:52 PM ET
    $ACI
    Food Chains
    Consumer Staples

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Leadership Updates

    Live Leadership Updates

    View All

    Albertsons Companies Names Allison Pinkham Executive Vice President and Chief Human Resources Officer

    Pinkham previously served as Chief Human Resources Officer at Galderma and Chief People Officer at Heineken USA Albertsons Companies, Inc. (NYSE:ACI) today announced that Allison Pinkham will join the Company as Executive Vice President and Chief Human Resources Officer effective Feb. 16, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126966952/en/Albertsons Companies Names Allison Pinkham Executive Vice President and Chief Human Resources Officer. Allison brings over 25 years of executive leadership and human resources experience to Albertsons Cos. Allison was most recently the Chief Human Resources Officer and Execu

    1/26/26 4:30:00 PM ET
    $ACI
    Food Chains
    Consumer Staples

    OSG Announces Appointment of Doug O'Reilly as Chief Information Officer and Mark Marin as Chief Revenue Officer

    CAROL STREAM, Ill., Jan. 22, 2026 /PRNewswire/ -- Output Services Group (OSG), a leading provider of Customer Communications Management (CCM) and Customer Experience Management (CXM) solutions, today announced the appointment of Doug O'Reilly as Chief Information Officer and Mark Marin as Chief Revenue Officer. Both executives are based in OSG's Carol Stream, Illinois headquarters. Doug joined OSG on January 14, 2026, and brings extensive experience leading enterprise technology organizations and modernizing complex platforms across large, regulated environments. Throughout hi

    1/22/26 10:02:00 AM ET
    $QUAD
    Publishing
    Consumer Discretionary

    Sonesta Appoints Keith Pierce and Jeff Leer as Co-Chief Executive Officers Effective April 1, 2026

    Sonesta International Hotels Corporation ("Sonesta") today announced that Keith Pierce, Executive Vice President and President of Franchise and Development at Sonesta, and Jeff Leer, Executive Vice President at The RMR Group (NASDAQ:RMR), have been appointed as Co-Chief Executive Officers of Sonesta, effective April 1, 2026. Mr. Pierce has been a member of Sonesta's executive leadership team since 2021, where he has been instrumental in leading the significant expansion of Sonesta's global franchising business. Prior to joining Sonesta, he held senior executive positions at The Passionality Group, Wyndham Hotel Group and Cendant Corporation. Mr. Leer, a member of RMR's management commit

    1/12/26 8:00:00 AM ET
    $RMR
    $SVC
    Professional Services
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Financials

    Live finance-specific insights

    View All

    Quad Announces 33% Increase in Quarterly Dividend

    SUSSEX, Wis., Feb. 13, 2026 /PRNewswire/ -- Quad/Graphics, Inc. (NYSE:QUAD) ("Quad" or the "Company"), a marketing experience company that solves complex marketing challenges for its clients, announced today that its Board of Directors approved a 33% increase in the quarterly dividend of the Company's common stock from $0.075 per share, or $0.30 per share on an annualized basis, to $0.10 per share, or $0.40 per share on an annualized basis. The Company also announced today that the Board of Directors declared a quarterly dividend on the Company's common stock at the increased

    2/13/26 8:30:00 AM ET
    $QUAD
    Publishing
    Consumer Discretionary

    Angel Oak Mortgage REIT, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    Angel Oak Mortgage REIT, Inc. (NYSE:AOMR) (the "Company," "we," and "our"), a leading real estate finance company focused on acquiring and investing in non-QM loans and other mortgage-related assets in the U.S. mortgage market, announced today that the Company will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 25, 2026. A conference call will be held that day at 8:30 a.m. Eastern Time. Webcast: A webcast of the conference call will be available on the Investors section of the Company's website at www.angeloakreit.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time in ord

    2/11/26 4:05:00 PM ET
    $AOMR
    Real Estate
    Finance

    Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

    Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company planning for rapid advancement of SENTI-202 into R/R AML pivotal study and evaluating indication expansion to include newly diagnosed AML and pediatric AML; Preparing for FDA discussions in the first half of 2026 SENTI-202 has received Regenerative Medicine Advanced Therapy (RMAT) designation, which may enable an expedited development and review process SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) --  Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generatio

    2/11/26 8:35:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACI
    $ACMR
    $ADMP
    $AFRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials